Zymeworks Inc. financial data

Symbol
ZYME on Nasdaq
Industry
Pharmaceutical Preparations
Location
108 Patriot Drive, Suite A, Middletown, DE
State of incorporation
DE
Fiscal year end
December 31
Former names
Zymeworks Delaware Inc. (to 10/13/2022)
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 610 % +13.8%
Debt-to-equity 27.5 % -10.8%
Return On Equity -27.1 % -161%
Return On Assets -21.3 % -162%
Operating Margin -222 % -601%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.9M shares -1.61%
Common Stock, Shares, Outstanding 69.6M shares +2.45%
Entity Public Float 469M USD +53.1%
Common Stock, Value, Issued 1.01B USD +8.82%
Weighted Average Number of Shares Outstanding, Basic 76.1M shares +7.87%
Weighted Average Number of Shares Outstanding, Diluted 76.2M shares +7.91%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 62.2M USD -86.5%
Research and Development Expense 130M USD -32.4%
General and Administrative Expense 60.1M USD -29.9%
Costs and Expenses 201M USD -21.9%
Operating Income (Loss) -138M USD -168%
Nonoperating Income (Expense) -618K USD +18%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -118M USD -154%
Income Tax Expense (Benefit) -4.35M USD -129%
Net Income (Loss) Attributable to Parent -114M USD -155%
Earnings Per Share, Basic -1.49 USD/shares -146%
Earnings Per Share, Diluted -1.48 USD/shares -146%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 122M USD +29.7%
Accounts Receivable, after Allowance for Credit Loss, Current 23.7M USD -64.8%
Assets, Current 344M USD -8.24%
Deferred Income Tax Assets, Net 4.21M USD +220%
Property, Plant and Equipment, Net 18.3M USD -12.3%
Operating Lease, Right-of-Use Asset 17.4M USD -2.81%
Goodwill 12M USD 0%
Assets 487M USD -12.4%
Employee-related Liabilities, Current 5.07M USD -7.92%
Contract with Customer, Liability, Current 27.2M USD +29134%
Liabilities, Current 83.9M USD +15.2%
Contract with Customer, Liability, Noncurrent 14.6M USD -55.7%
Deferred Income Tax Liabilities, Net 3.46M USD +75.6%
Operating Lease, Liability, Noncurrent 17.3M USD -22.9%
Other Liabilities, Noncurrent 929K USD -50%
Liabilities 120M USD -8.97%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6M USD +27.7%
Retained Earnings (Accumulated Deficit) -798M USD -20.3%
Stockholders' Equity Attributable to Parent 367M USD -13.5%
Liabilities and Equity 487M USD -12.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.7M USD +54.7%
Net Cash Provided by (Used in) Financing Activities 2.12M USD +22.2%
Net Cash Provided by (Used in) Investing Activities -7.32M USD +94.7%
Common Stock, Shares Authorized 900M shares 0%
Common Stock, Shares, Issued 69.6M shares +2.45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -42.7M USD +80.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 122M USD +29.7%
Deferred Tax Assets, Valuation Allowance 222M USD +54.1%
Deferred Tax Assets, Gross 235M USD +50%
Operating Lease, Liability 20.2M USD -23%
Depreciation 1.06M USD -33%
Payments to Acquire Property, Plant, and Equipment 185K USD -52.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -111M USD -155%
Lessee, Operating Lease, Liability, to be Paid 23.6M USD -24.1%
Property, Plant and Equipment, Gross 40.5M USD +6.55%
Operating Lease, Liability, Current 2.94M USD -23.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.35M USD -30.1%
Deferred Tax Assets, Operating Loss Carryforwards 597M USD +89.8%
Preferred Stock, Shares Issued 1 shares 0%
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 3.08M USD +0.46%
Operating Lease, Payments 4.55M USD -20.8%
Preferred Stock, Shares Outstanding 1 shares 0%
Amortization of Intangible Assets 702K USD +3.39%
Deferred Tax Assets, Net of Valuation Allowance 3.62M USD +169%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%